| الوصف: |
This review is devoted to the analysis of the results of research on the peculiarities of the interrelationships of the autonomic nervous system with glucose metabolism, circadian rhythms, and heart rate variability, as well as the clinical significance of heart rate variability in diabetes. In the review, thematic blocks are formed, which could be used from the perspective of scientific research on this problem. Анотація Цей огляд присвячено аналізу результатів досліджень особливостей взаємозв’язків вегетативної нервової системи з метаболізмом глюкози; циркадним ритмам і варіативності ритму серця, а також клінічного значення варіативності ритму серця при цукровому діабеті. У огляді формуються тематичні блоки, які могли б бути використані в перспективі наукових досліджень по даній проблемі
Список літератури: 1. Thorens B. Neural regulation of pancreatic islet cell mass and function. Diabetes Obes Metab. 2014 Sep;16 Suppl 1:87-95. https://doi.org/10.1111/dom.12346. 2. Dimova R, Chakarova N, Grozeva G, Tankova T. Evaluation of the relationship between cardiac autonomic function and glucose variability and HOMA-IR in prediabetes. Diab Vasc Dis Res. 2020 May-Jun;17(5):1479164120958619. doi: 10.1177/1479164120958619. 3. Moullé VS, Tremblay C, Castell AL, Vivot K, Ethier M, Fergusson G, et al. The autonomic nervous system regulates pancreatic β-cell proliferation in adult male rats. Am J Physiol Endocrinol Metab. 2019 Aug 1;317(2):E234-E243. https://doi.org/10.1152/ajpendo.00385.2018. 4. Ziegler D, Strom A, Bönhof G, Püttgen S, Bódis K, Burkart V, et al.; GDS group. Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes. Metabolism. 2018 Feb;79:1-9. https://doi.org/10.1016/j.metabol.2017.10.013. 5. Ziegler D, Strom A, Straßburger K, Knebel B, Bönhof GJ, Kotzka J, et al.; German Diabetes Study group. Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes. Diabetologia. 2021 Feb;64(2):458-468. https://doi.org/10.1007/s00125-020-05310-5. 6. Bulloch JM, Daly CJ. Autonomic nerves and perivascular fat: interactive mechanisms. Pharmacol Ther. 2014 Jul;143(1):61-73. https://doi.org/10.1016/j.pharmthera.2014.02.005. 7. Barzilay JI, Tressel W, Biggs ML, Stein PK, Kizer JR, Shitole SG, et al. The Association of Measures of Cardiovascular Autonomic Function, Heart Rate, and Orthostatic Hypotension With Incident Glucose Disorders: The Cardiovascular Health Study. Diabetes Care. 2022 Oct 1;45(10):2376-2382. https://doi.org/10.2337/dc22-0553. 8. Shaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017 Sep 28;5:258. https://doi.org/10.3389/fpubh.2017.00258. 9. Wulsin L, Herman J, Thayer JF. Stress, autonomic imbalance, and the prediction of metabolic risk: A model and a proposal for research. Neurosci Biobehav Rev. 2018 Mar;86:12-20. https://doi.org/10.1016/j.neubiorev.2017.12.010. 10. Serhiyenko VA, Serhiyenko LM, Serhiyenko AA. Features of circadian rhythms of heart rate variability, arterial stiffness and outpatient monitoring of blood pressure in diabetes mellitus: Data, mechanisms and consequences. In: Sinha RP, editor. Circadian Rhythms and Their Importance, New York: Nova Science Publishers; 2022. p. 279-341. https://doi.org/10.52305/GXME8274. 11. Jarczok MN, Guendel H, McGrath JJ, Balint EM. Сircadian Rhythms of the Autonomic Nervous System: Scientific Implication and Practical Implementation. In: Svorc P, editor. Chronobiology - The Science of Biological Time Structure. London. UK: IntechOpen; 2019. 108 p. http://dx.doi.org/10.5772/intechopen.86822. 12. Serhiyenko VA, Serhiyenko LM, Sehin VB, Serhiyenko AA. Pathophysiological and clinical aspects of the circadian rhythm of arterial stiffness in diabetes mellitus: A minireview. Endocr Regul. 2022 Oct 20;56(4):284-294. https://doi.org/10.2478/enr-2022-0031. 13. Hall JE. Guyton and Hall Textbook of Medical Physiology (Guyton Physiology). 13th ed. New Delhi: ELSEVIER; 2016. 1168 p. ISBN-13: 978-1455770052. 14. Yaniv Y, Ahmet I, Tsutsui K, Behar J, Moen JM, Okamoto Y, et al. Deterioration of autonomic neuronal receptor signaling and mechanisms intrinsic to heart pacemaker cells contribute to age-associated alterations in heart rate variability in vivo. Aging Cell. 2016 Aug;15(4):716-24. https://doi.org/10.1111/acel.12483. 15. Morales IO, Landa E, Angeles CC, Toledo JC, Rivera AL, Temis JM, Frank A. Behavior of Early Warnings near the Critical Temperature in the Two-Dimensional Ising Model. PLoS One. 2015 Jun 23;10(6):e0130751. https://doi.org/10.1371/journal.pone.0130751. 16. Albarado-Ibañez A, Arroyo-Carmona RE, Sánchez-Hernández R, Ramos-Ortiz G, Frank A, García-Gudiño D, et al. The Role of the Autonomic Nervous System on Cardiac Rhythm during the Evolution of Diabetes Mellitus Using Heart Rate Variability as a Biomarker. J Diabetes Res. 2019 May 9;2019:5157024. https://doi.org/10.1155/2019/5157024. 17. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. PMID: 8598068. 18. Bagherzadeh A, Nejati-Afkham A, Tajallizade-Khoob Y, Shafiee A, Sharifi F, Esfahani MA, et al. Association of cardiac autonomic neuropathy with arterial stiffness in type 2 diabetes mellitus patients. J Diabetes Metab Disord. 2013 Dec 20;12(1):55. https://doi.org/10.1186/2251-6581-12-55. 19. Arroyo-Carmona RE, López-Serrano AL, Albarado-Ibañez A, Mendoza-Lucero FM, Medel-Cajica D, López-Mayorga RM, et al. Heart Rate Variability as Early Biomarker for the Evaluation of Diabetes Mellitus Progress. J Diabetes Res. 2016;2016:8483537. https://doi.org/10.1155/2016/8483537. 20. Malik M, Hnatkova K, Huikuri HV, Lombardi F, Schmidt G, Zabel M. CrossTalk proposal: Heart rate variability is a valid measure of cardiac autonomic responsiveness. J Physiol. 2019 May;597(10):2595-2598. https://doi.org/10.1113/JP277500. 21. Karmakar C, Udhayakumar R, Palaniswami M. Entropy Profiling: A Reduced-Parametric Measure of Kolmogorov-Sinai Entropy from Short-Term HRV Signal. Entropy (Basel). 2020 Dec 10;22(12):1396. https://doi.org/10.3390/e22121396. 22. Ernst G. Heart-Rate Variability-More than Heart Beats? Front Public Health. 2017 Sep 11;5:240. https://doi.org/10.3389/fpubh.2017.00240. 23. Ferdousi S. and Gyeltshen P. Type 2 diabetes mellitus: cardiovascular autonomic neuropathy and heart rate variability. In: Pantea-Stoian A, editor. Type 2 Diabetes: From Pathophysiology to Cyber Systems. London, UK: IntechOpen; 2021. p. 215-306. http://dx.doi.org/10.5772/intechopen.95515. 24. Yang Y, Lee EY, Cho JH, Park YM, Ko SH, Yoon KH, et al. Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus. Diabetes Metab J. 2018 Dec;42(6):496-512. https://doi.org/10.4093/dmj.2018.0026. 25. Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic Nervous System Dysfunction: JACC Focus Seminar. J Am Coll Cardiol. 2019 Mar 19;73(10):1189-1206. https://doi.org/10.1016/j.jacc.2018.12.064. 26. Hillebrand S, Gast KB, de Mutsert R, Swenne CA, Jukema JW, Middeldorp S,et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013 May;15(5):742-9. https://doi.org/10.1093/europace/eus341. 27. Fyfe-Johnson AL, Muller CJ, Alonso A, Folsom AR, Gottesman RF, Rosamond WD, et al. Heart Rate Variability and Incident Stroke: The Atherosclerosis Risk in Communities Study. Stroke. 2016 Jun;47(6):1452-8. https://doi.org/10.1161/STROKEAHA.116.012662. 28. Sacha J. Interplay between heart rate and its variability: a prognostic game. Front Physiol. 2014 Sep 12;5:347. https://doi.org/10.3389/fphys.2014.00347. 29. Kück JL, Bönhof GJ, Strom A, Zaharia OP, Müssig K, Szendroedi J, et al.; GDS group. Impairment in Baroreflex Sensitivity in Recent-Onset Type 2 Diabetes Without Progression Over 5 Years. Diabetes. 2020 May;69(5):1011-1019. https://doi.org/10.2337/db19-0990. 30. Bakkar NZ, Dwaib HS, Fares S, Eid AH, Al-Dhaheri Y, El-Yazbi AF. Cardiac Autonomic Neuropathy: A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders. Int J Mol Sci. 2020 Nov 27;21(23):9005. https://doi.org/10.3390/ijms21239005. 31. Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes. 2018 Jan 15;9(1):1-24. https://doi.org/10.4239/wjd.v9.i1.1. 32. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014 Feb 15;5(1):17-39. https://doi.org/10.4239/wjd.v5.i1.17. 33. Andersen ST, Witte DR, Fleischer J, Andersen H, Lauritzen T, Jørgensen ME, et al. Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark. Diabetes Care. 2018 Dec;41(12):2586-2594. https://doi.org/10.2337/dc18-1411. 34. Aeschbacher S, Schoen T, Dörig L, Kreuzmann R, Neuhauser C, Schmidt-Trucksäss A, et al. Heart rate, heart rate variability and inflammatory biomarkers among young and healthy adults. Ann Med. 2017 Feb;49(1):32-41. https://doi.org/10.1080/07853890.2016.1226512. 35. Kemp AH, Koenig J, Thayer JF. From psychological moments to mortality: A multidisciplinary synthesis on heart rate variability spanning the continuum of time. Neuroscience & Biobehavioral Reviews. 2017;83(March):547-567. https://doi.org/10.1016/j.neubiorev.2017.09.006. 36. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y,et al.; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010 Dec;24(12):779-85. https://doi.org/10.1038/jhh.2010.54. 37. Stuckey MI, Petrella RJ. Heart rate variability in type 2 diabetes mellitus. Crit Rev Biomed Eng. 2013;41(2):137-47. https://doi.org/10.1615/critrevbiomedeng.2013008103. 38. Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013;98(4):267-80. https://doi.org/10.1159/000358728. 39. O'Brien E. Sleepers versus nonsleepers: another twist to the dipper/nondipper concept. Hypertension. 2007 Apr;49(4):769-70. https://doi.org/10.1161/01.HYP.0000258152.29476.de. 40. Tarvainen MP, Cornforth DJ, Kuoppa P, Lipponen JA, Jelinek HF. Complexity of heart rate variability in type 2 diabetes - effect of hyperglycemia. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:5558-61. https://doi.org/10.1109/EMBC.2013.6610809. 41. Tarvainen MP, Laitinen TP, Lipponen JA, Cornforth DJ, Jelinek HF. Cardiac autonomic dysfunction in type 2 diabetes - effect of hyperglycemia and disease duration. Front Endocrinol (Lausanne). 2014 Aug 8;5:130. https://doi.org/10.3389/fendo.2014.00130. 42. Burnstock G. Cotransmission in the autonomic nervous system. Handb Clin Neurol. 2013;117:23-35. https://doi.org/10.1016/B978-0-444-53491-0.00003-1. 43. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed). 1982 Oct 2;285(6346):916-8. https://doi.org/10.1136/bmj.285.6346.916. 44. Sammito S, Böckelmann I. Factors influencing heart rate variability. ICFJ. 2016; 6:18-22. https://doi.org/10.17987/icfj.v6i0.242. Sammito S, Böckelmann I. Factors influencing heart rate variability. ICFJ. 2016;6:18-22. https://doi.org/10.17987/icfj.v6i0.242. 45. Trivedi GY, Saboo B, Singh RB, Maheshwari A, Sharma K, Verma N. Can decreased heart rate variability be a marker of autonomic dysfunction, metabolic syndrome and diabetes? J Diabetol. 2019 May 1;10(2):48-56. https://doi.org/10.4103/jod.jod_17_18. 46. Ziegler D, Voss A, Rathmann W, Strom A, Perz S, Roden M, et al.; KORA Study Group. Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey. Diabetologia. 2015 May;58(5):1118-28. https://doi.org/10.1007/s00125-015-3534-7. |
